Feel Therapeutics is excited to announce the successful closing of a $7,880,000 funding round, marking a pivotal moment in our journey to revolutionize mental health care. As a Digital Precision Medicine company, we are committed to bringing objective data and passive monitoring to the mental health landscape, aiming to transform traditional diagnostic and treatment paradigms. With the backing of esteemed investors such as Felicis, Anthemis, and SOSV, this new investment not only validates our innovative approach but also paves the way for accelerated research and development of novel digital biomarkers. These initiatives will broaden our ability to develop cutting-edge digital health solutions, whether they are deployed as standalone therapeutics (DTx) or used in conjunction with existing medications. Our strategic partnerships with large pharmaceutical companies further reinforce our capacity to integrate state-of-the-art digital tools with clinical expertise, ensuring that we can offer more precise, data-driven care to individuals battling mental health challenges. This funding will be instrumental in expanding our technological capabilities, enhancing the scalability of our platform, and ultimately driving forward our mission to redefine mental health diagnostics, patient management, and overall care. By harnessing the power of digital precision medicine, Feel Therapeutics is setting a new standard in mental health care, ultimately aiming to improve outcomes and quality of life for patients worldwide. We invite you to learn more about our transformative work and vision by visiting www.feeltherapeutics.com or reaching out to us directly at info@feeltherapeutics.com.
Feel Therapeutics Secures $7.88M to Transform Mental Health with Digital Precision Medicine Innovations
Recently funded · $7.9MHealthcare
Get the full Feel Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
